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Abstract
Background: Obesity is a significant global health problem, with the proportion of women entering pregnancy
with a body mass index greater than or equal to 25 kg/m
2 approaching 50%. Obesity during pregnancy is
associated with a well-recognised increased risk of adverse health outcomes both for the woman and her infant,
however there is more limited information available regarding effective interventions to improve health outcomes.
The aims of this randomised controlled trial are to assess whether the implementation of a package of dietary and
lifestyle advice to overweight and obese women during pregnancy to limit gestational weight gain is effective in
improving maternal, fetal and infant health outcomes.
Methods/Design: Design: Multicentred randomised, controlled trial.
Inclusion Criteria: Women with a singleton, live gestation between 10
+0-20
+0 weeks who are obese or overweight
(defined as body mass index greater than or equal to 25 kg/m
2), at the first antenatal visit.
Trial Entry & Randomisation: Eligible, consenting women will be randomised between 10
+0 and 20
+0 weeks
gestation using a central telephone randomisation service, and randomisation schedule prepared by non-clinical
research staff with balanced variable blocks. Stratification will be according to maternal BMI at trial entry, parity,
and centre where planned to give birth.
Treatment Schedules: Women randomised to the Dietary and Lifestyle Advice Group will receive a series of inputs
from research assistants and research dietician to limit gestational weight gain, and will include a combination of
dietary, exercise and behavioural strategies.
Women randomised to the Standard Care Group will continue to receive their pregnancy care according to local
hospital guidelines, which does not currently include routine provision of dietary, lifestyle and behavioural advice.
Outcome assessors will be blinded to the allocated treatment group.
Primary Study Outcome: infant large for gestational age (defined as infant birth weight ≥ 90
th centile for
gestational age).
Sample Size: 2,180 women to detect a 30% reduction in large for gestational age infants from 14.40% (p = 0.05,
80% power, two-tailed).
Discussion: This is a protocol for a randomised trial. The findings will contribute to the development of evidence
based clinical practice guidelines.
Trial Registration: Australian and New Zealand Clinical Trials Registry ACTRN12607000161426
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Obesity: the burden of disease
Obesity has been identified by the World Health Organisa-
tion as a significant global health problem, [1] contributing
to the overall burden of disease worldwide [2]. Obesity is
associated with a reduction in life expectancy, through an
increased risk of adverse health consequences related to
cardiovascular disease, type 2 diabetes and several cancers
[2].
The impact of obesity during pregnancy
Obesity is a significant health issue for women during
pregnancy and childbirth, with estimates suggesting that
35% of Australian women aged between 25 and 35 years
are overweight or obese [3]. Approximately 34% of preg-
nant women have a body mass index (BMI) in excess of
25 kg/m
2, [4] although recent data indicates this to be
increasing further, and approaching 50% [5,6]. There are
well-documented risks associated with obesity during
pregnancy. Maternal complications include an increased
risk of hypertension and pre-eclampsia, [4-17] gestational
diabetes, [4-6,10,11,15,16] infection [13] and thromboem-
bolic disease [9,13]. Women who are overweight or obese
are more likely to require induction of labour, [5,6,10,13,
14,16] and have increased risk of caesarean section
[4-6,10-18]. Women who are overweight or obese are
more likely to suffer a perinatal death [4,10,12,14,17-22].
Infants of mothers who are overweight or obese are more
likely to be macrosomic, [5,6,15,17,19-21] require admis-
sion to the neonatal intensive care unit, [4,6,19-21] be
born preterm, [4,6,19-21] be identified with a congenital
anomaly, [4,19-21] and to require treatment for jaundice
or hypoglycaemia [4,6,16].
We have published maternal and infant health outcome
data available for all women birthing in South Australia
in 2008, involving in excess of 19,600 confinements [6].
Risk ratios (RR) and 95% confidence intervals (CI) for
health outcomes for women in various BMI categories
were compared with women of healthy BMI (less than
25 kg/m
2), demonstrating an increased risk in adverse
maternal and infant health outcomes with increasing
maternal BMI, [6] consistent with other reported litera-
ture [4,5].
Gestational weight gain recommendations
There is a substantial literature on maternal weight gain
in pregnancy that has been summarised by the Institute
of Medicine [23,24]. While most studies have reported
average weight gains of 10-15 kg, this varied considerably
among overweight and obese women, with many women
exceeding this average [23].
Cedergren and colleagues evaluated the effect of mater-
nal BMI and gestational weight gain in more than
240,000 women in Sweden [25]. While obese women
with gestational weight gain less than 8 kg had a reduced
risk of large-for-gestational age babies, pre-eclampsia,
caesarean section and operative vaginal birth, high gesta-
tional weight gain was associated with an increased rate
of caesarean section across each of the 5 BMI categories.
Cedergren concluded that obese women may benefit
from a limited weight gain in pregnancy, as has been
recommended by the Institute of Medicine [23,24].
Conversely, too severe restriction of maternal diet may
have implications for fetal growth and development.
While Cedergren and colleagues demonstrated a reduction
in the risk of large for gestational age infants among
women with less than 8 kg weight gain in pregnancy, this
appeared to be at the expense of an increase in the
proportion of small infants at the opposite end of the
birth-weight spectrum [25]. This finding has not been
demonstrated in the randomised trial ACHOIS [13]
where, for women with gestational diabetes, treatment
with dietary and exercise advice designed not to promote
weight loss was associated with a significant reduction in
the incidence of macrosomia without any increase in the
risk of small for gestational age infants.
While restriction of weight gain in pregnancy increases
the incidence of spontaneous preterm birth in women
with a normal BMI, this has not been demonstrated in
overweight or obese women [26]. Thus recommendations
have been made to avoid weight loss during pregnancy
and to limit restriction of weight gain to approximately
5 kg throughout pregnancy [27].
Reducing the burden of disease related to Obesity in
Pregnancy
While there is an extensive body of literature related to
defining the problems and potential complications asso-
ciated with obesity during pregnancy and childbirth, there
is more limited information available related to effective
interventions that may be implemented to improve mater-
nal, fetal and infant health outcomes. Current practice
guidelines recommend that women should be counselled
prior to conception and encouraged to make lifestyle
changes [28].
Systematic Review of the Literature
Our systematic review published in 2008 [29] identified 2
published randomised trials, assessing antenatal interven-
tions for overweight and obese women during pregnancy.
Our updated systematic review and meta-analysis pub-
lished in 2010 included 9 randomised trials, involving
743 women and infants [30]. There were no statistically
significant differences identified between women who
received an antenatal intervention and those who did not
for the outcome large-for-gestational-age infant (three
studies; 366 women; risk ratio 2.02; 95% CI 0.84, 4.86) or
mean gestational weight gain (four studies; 416 women;
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(random effects model). There were no statistically signif-
icant differences identified for other reported outcomes.
To summarise
There are limitations of the current evidence on the effect
of an antenatal dietary intervention to limit gestational
weight gain for women who are overweight or obese,
including the lack of reporting of maternal and infant
outcomes.
Aims of the trial
The aims of this randomised, controlled trial are to assess
whether the implementation of a package of dietary and
lifestyle advice to overweight and obese women during
pregnancy to limit weight gain is effective in improving
maternal, fetal and infant health outcomes.
Trial hypotheses
The primary hypothesis is that the implementation of a
package of dietary and lifestyle advice to overweight and
obese women during pregnancy to limit gestational
weight gain will
￿ reduce the risk of the infant born large for gesta-
tional age (defined as infant birth weight ≥ 90
th centile
for gestational age and infant sex).
The secondary hypotheses are that the implementation
of a package of dietary and lifestyle advice to overweight
and obese women during pregnancy to limit gestational
weight gain will
￿ reduce the risk of morbidity from other adverse
outcomes for the infant; and
￿ reduce the risk of maternal morbidity from
pregnancy complications and adverse outcomes.
Methods/Design
Study Design: Multicentred randomised controlled trial.
Inclusion Criteria: Women with a singleton, live gesta-
tion between 10
+0-20
+0 weeks who are obese or overweight
(defined as a body mass index greater than or equal to
25 kg/m
2), at their first antenatal visit.
Exclusion Criteria: Women with a multiple pregnancy,
or type 1 or 2 diabetes diagnosed prior to pregnancy.
Trial Entry: Eligible women will be identified in the
antenatal clinic, given the trial information sheet and
counselled by the researcher, before obtaining informed
written consent. Randomisation will occur between 10
+0
and 20
+0 weeks gestation by telephoning the central ran-
domisation service. The randomisation schedule will use
balanced variable blocks, and will be prepared by an inves-
tigator not involved with recruitment or clinical care.
There will be stratification of women according to parity
(parity 0 versus parity 1 or more), body mass index at
booking visit (BMI 25-29.9 kg/m
2 versus BMI ≥ 30 kg/
m
2), and collaborating centre.
Treatment Schedules: Eligible women will be rando-
mised and allocated a study number corresponding to
either the ‘Dietary and Lifestyle Advice Group’ or the
‘Standard Care Group’.
Women randomised to the Dietary and Lifestyle
Advice Group will receive a comprehensive intervention
to limit weight gain in pregnancy that includes a combi-
nation of dietary, exercise and behavioural strategies,
delivered by a research dietician and trained research
assistants. Women will be provided with dietary advice
consistent with current Australian dietary standards, [31]
that maintains a balance of carbohydrates, fat and pro-
tein. Women will be encouraged to reduce their intake of
foods high in refined carbohydrates and saturated fats,
while increasing their intake of fibre, and promoting
consumption of two serves of fruit and five serves of
vegetables each day [31]. Exercise advice will focus on
encouraging women to adopt a more active lifestyle, pri-
marily by increasing the amount of walking [32]. Tailor-
ing of the intervention will be informed by stage theories
of health decision making that propose that individuals
progress through a series of cognitive phases when
undertaking behavioural change [33].
Initially, there will be a planning session with a research
dietician, in which women are provided with written dietary
and activity information, an individual diet and physical
activity plan, a food and activity diary, recipe book and
example menu plans. Women will be encouraged to set
achievable goals for dietary and exercise change, supported
to make these lifestyle changes and to self-monitor their
progress. Additionally, women will be encouraged to iden-
tify potential barriers and enablers to facilitate the imple-
mentation of their goals. This information will be
reinforced during subsequent inputs at regular intervals
during pregnancy, provided by the research dietician (at 28
weeks’ gestation) and trained research assistants (via tele-
phone call at 22, 24, and 32 weeks’ gestation and a face-face
visit at 36 weeks’ gestation).
Women randomised to the Standard Care Group will
continue to receive their pregnancy care according to local
hospital guidelines, which does not currently include rou-
tine provision of dietary, lifestyle and behavioural advice.
Follow-up of women in both treatment groups: All
women will continue to have their clinical care provided
by clinicians at their planned hospital of birth. After birth,
information will be obtained relating to birth and infant
outcomes from the case notes by a research assistant not
involved in the provision of the intervention, and blinded
to treatment allocation. Similarly, the postnatal and neona-
tal forms will be completed for each live born infant after
discharge from hospital. Outcomes will be determined at
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partum, whichever is greater.
Study Endpoints: The primary study outcome is:
￿ Infant large for gestational age (defined as birth
weight ≥ 90
th centile for gestational age).
The secondary study outcomes are
1) Adverse outcomes for the infant including preterm
birth (defined as birth at less than 37 weeks gestation);
mortality (defined as either a stillbirth (intrauterine fetal
death after trial entry and prior to birth), or infant death
(death of a live born infant prior to hospital discharge, and
excluding lethal congenital anomalies)); congenital anoma-
lies; infant birth weight ≥ 4000 grams; hypoglycaemia
requiring intravenous treatment; admission to neonatal
intensive care unit, or special care baby unit; hyperbilirubi-
naemia requiring phototherapy; nerve palsy; fracture; birth
trauma; shoulder dystocia.
2) Adverse outcomes for the woman including mater-
nal hypertension and pre-eclampsia (in accordance with
recognised Australasian Society for the Study of Hyperten-
sion in Pregnancy criteria) [34]; maternal gestational dia-
betes (defined as a positive oral glucose tolerance test with
fasting blood glucose level ≥ 5.5 mmol/L, or 2 hour blood
glucose level ≥ 7.8 mmol/L); need for and length of antena-
tal hospital stay; antepartum haemorrhage requiring hospi-
talisation; preterm prelabour ruptured membranes;
chorioamnionitis requiring antibiotic use during labour;
need and reason for induction of labour; any antibiotic use
during labour; caesarean section; postpartum haemorrhage
(defined as blood loss ≥ 600 mL); perineal trauma; wound
infection; endometritis; use of postnatal antibiotics; length
of postnatal hospital stay; thromboembolic disease; mater-
nal death.
Sample Size: The clinical endpoint of infant large for
gestational age has been chosen as the primary outcome
for this trial. Population studies consistently identify high
infant birth weight as a significant, independent factor
associated with a 2-3 fold increased odds of obesity at age
4 yrs, [35,36] and more accurately assesses size at birth
than weight above a particular cut-off value. We estimate
the incidence of infant large for gestational age in women
eligible for this trial to be 14.4% [37]. To reduce this by
30% to 10.1% (alpha 0.05; power 80%; two-tailed test), and
allowing for 15% loss to follow-up, we will need to recruit
a total of 2,180 women.
Analysis and Reporting of Results: The initial analysis
will examine baseline characteristics of all randomised
women, as an indication of comparable treatment groups.
Outcome comparisons for women and infants will be ana-
lysed for the primary and secondary outcomes on an
“intention to treat” basis, according to treatment allocation
at randomisation to either dietary and lifestyle group or
standard care group. The relative risks and 95% confidence
intervals will be reported for the major outcomes, and the
number needed to treat to prevent one adverse outcome
will be calculated. Regression techniques will be used to
examine the influence of prognostic factors on the major
outcomes. Pre-specified secondary analyses will explore
the effect of maternal BMI, gestational weight gain and
parity on clinical outcomes.
Approval to conduct this study has been obtained from
the following research and ethics committees: Women’s
and Children’s Hospital (Adelaide, South Australia);
Flinders Medical Centre (Adelaide, South Australia); Lyell
McEwin Health Service (Adelaide, South Australia); The
Queen Elizabeth Hospital (Adelaide, South Australia).
Discussion
This is a protocol for a randomised trial assessing whether
the implementation of a package of dietary and lifestyle
advice to overweight and obese women during pregnancy
to limit gestational weight gain is effective in improving
maternal, fetal and infant health outcomes. The findings
of this trial will contribute to the currently available litera-
ture regarding the effect of limiting gestational weight gain
for women who are overweight or obese, and to the devel-
opment of evidence based clinical practice guidelines.
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